AmbioPharm
Tracked across 2 events · 13 articles · First seen May 27, 2026 · Last active Sep 17, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: AmbioPharm is being acquired by CordenPharma, which will integrate its peptide manufacturing capabilities and facilities into CordenPharma's global network, allowing its shareholders to reinvest in the combined business.
May 27, 2026 · 7 articles
Business
CordenPharma, a global pharmaceutical contract development and manufacturing organization (CDMO) backed by private equity firm Astorg, announced the appointment of Dr. Jean-Luc Herbeaux as Chief Executive Officer effective 1 October 2026. Herbeaux succeeds Dr. Michael…
Impact: AmbioPharm is referenced as the peptide CDMO recently acquired by CordenPharma, cited as evidence of the company's expansion under the outgoing CEO. It plays no active role in the leadership change itself.
Sep 15, 2026 · 6 articles
40
CordenPharma acquired AmbioPharmCordenPharma CEO...
ERGEN INTELLIGENCE
Track AmbioPharm live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard